Abstract
Target-mediated drug disposition (TMDD) models have been applied to describe the pharmacokinetics of drugs whose distribution and/or clearance are affected by its target due to high binding affinity and limited capacity. The Michaelis-Menten (M-M) model has also been frequently used to describe the pharmacokinetics of such drugs. The purpose of this study is to investigate conditions for equivalence between M-M and TMDD pharmacokinetic models and provide guidelines for selection between these two approaches. Theoretical derivations were used to determine conditions under which M-M and TMDD pharmacokinetic models are equivalent. Computer simulations and model fitting were conducted to demonstrate these conditions. Typical M-M and TMDD profiles were simulated based on literature data for an anti-CD4 monoclonal antibody (TRX1) and phenytoin administered intravenously. Both models were fitted to data and goodness of fit criteria were evaluated for model selection. A case study of recombinant human erythropoietin was conducted to qualify results. A rapid binding TMDD model is equivalent to the M-M model if total target density R tot is constant, and R tot K D /(K D + C) 2 1 where K D represents the dissociation constant and C is the free drug concentration. Under these conditions, M-M parameters are defined as: V max = k int R tot V c and K m = K D where k int represents an internalization rate constant, and V c is the volume of the central compartment. R tot is constant if and only if k int = k deg, where k deg is a degradation rate constant. If the TMDD model predictions are not sensitive to k int or k deg parameters, the condition of R tot K D /(K D + C) 2 1 alone can preserve the equivalence between rapid binding TMDD and M-M models. The model selection process for drugs that exhibit TMDD should involve a full mechanistic model as well as reduced models. The best model should adequately describe the data and have a minimal set of parameters estimated with acceptable precision.
| Original language | English |
|---|---|
| Pages (from-to) | 25-47 |
| Number of pages | 23 |
| Journal | Journal of Pharmacokinetics and Pharmacodynamics |
| Volume | 37 |
| Issue number | 1 |
| DOIs | |
| State | Published - Feb 2010 |
Keywords
- Erythropoietin
- Michaels-Menten
- Nonlinear pharmacokinetics
- Target-mediated drug disposition
Fingerprint
Dive into the research topics of 'Selection between Michaelis-Menten and target-mediated drug disposition pharmacokinetic models'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver